Specialities and Expertise:Vaccines Technology, Oral Vaccines, Therapeutic Vaccine, Vaccine Development, Recombinant Influenza Vaccine (RIV), Prophylactic Vaccines, Preclinical Vaccine, Biotechnology, Health Care, Medical Devices, Tablet Vaccine, Oral Recombinant Vaccines, Vector-Adjuvant Platform, Therapeutic Vaccine, Human Papillomavirus (HPV) Vaccine, Prophylactic and Therapeutic Vaccines, Vaccines Research & Development, Immuno-Oncology, Norovirus Tablet Vaccine, SARS-CoV-2, Coronavirus, COVID-19.
Size and Minority Status
- Products and services 1
- Сommodity codes
Vaxart oral vaccine platform uses adenovirus type 5 (Ad5) virus to help train the immune system to recognize and defeat pathogens. Vaxart recombinantly removes the DNA and thus stops viral replication.
Locations Served 2
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.